Possible association of the alpha-2A adrenergic receptor gene (ADRA2A) with symptoms of attention-deficit/hyperactivity disorder

American Journal of Medical Genetics - Neuropsychiatric Genetics

Volumn 141 B, Issue 2, 2006, Pages 130-134

  Wang, Bing ^a   Wang, Yufeng ^a   Zhou, Rulun ^a   Li, Jun ^a   Qian, Qiujin ^a   Yang, Li ^a   Guan, Lili ^a   Faraone, Stephen V ^b  

^a PEKING UNIVERSITY   (China)

^b State University of New York Upstate Medical University: College of Medicine   (United States)

Author keywords

ADRA2A gene; Attention deficit hyperactivity disorder; Haplotype; Symptom; Transmission disequilibrium

Indexed keywords

ALPHA 2A ADRENERGIC RECEPTOR;

ADOLESCENT; ADRA2A GENE; ARTICLE; ATTENTION DEFICIT DISORDER; CAUCASIAN; CHILD; CHINESE; FAMILY STUDY; FEMALE; GENE; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HAPLOTYPE; HUMAN; INHERITANCE; MAJOR CLINICAL STUDY; MALE; NORADRENERGIC SYSTEM; PRIORITY JOURNAL; SYMPTOMATOLOGY; TRANSMISSION DISEQUILIBRIUM TEST;

ADOLESCENT; ALLELES; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CHILD; FEMALE; GENE FREQUENCY; GENOTYPE; HAPLOTYPES; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; POLYMORPHISM, GENETIC; RECEPTORS, ADRENERGIC, ALPHA-2;

ANIMALIA;

EID: 32244448530     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.b.30258     Document Type: Article

References (29)

1. Arnsten AF. 1998. Catecholamine modulation of prefrontal cortical cognitive function. Trends Cogn Sci 2(11):436-447.
2. Arnsten AF. 2000. Genetics of childhood disorders: XVIII. ADHD, Part. 2: Norepinephrine has a critical modulatory influence on prefrontal cortical function. J Am Acad Child Adolesc Psychiatry 39(9):1201-1203.
3. Arnsten AF, Steere JC, Hunt RD. 1996. The contribution of alpha 2-noradrenergic mechanisms of prefrontal cortical cognitive function. Potential significance for attention-deficit hyperactivity disorder. Arch Gen Psychiatry 53(5):448-455.
4. Aston-Jones G, Foote SJ, Bloom FE. 1984. Anatomy and physiology of locus coeruleus neurons: Functional implications. In: Zeigler MG, Lake CR, editors. Norepinephrine: Clinical aspects. Baltimore: Williams & Wilkins. pp 92-116.
5. Barkley RA. 1997. Behavioral inhibition, sustained attention, and executive functions: Constructing a unifying theory of ADHD. Psychol Bull 121(1): 65-94.
6. Barkley RA. 1998. Attention-deficit hyperactivity disorder: A clinical workbook. 2nd edition. New York: Guilford. pp 39-55.
7. Biederman J, Spencer T. 1999. Attention-deficit/hyperactivity disorder (ADHD) as a noradrenergic disorder. Biol Psychiatry 46(9):1234-1242.
8. Clayton D. 1999. A generalization of the transmission/disequilibrium test for uncertain-haplotype transmission. Am J Hum Genet 65(4):1170-1177.
9. Comings DE, Gade-Andavolu R, Gonzalez N, Blake H, Wu S, MacMurray JP. 1999. Additive effect of three noradrenergic genes (ADRA2A, ADRA2C, DBH) on attention-deficit hyperactivity disorder and learning disabilities in Tourette syndrome subjects. Clin Genet 55(3):160-172.
10. Connor DF, Fletcher KE, Swanson JM. 1999. A meta-analysis of clonidine for symptoms of attention-deficit hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 38(12):1551-1559.
11. Davies MF, Tsui JY, Flannery JA, Li X, DeLorey TM, Hoffman BB. 2003. Augmentation of the noradrenergic system in alpha-2 adrenergic receptor deficient mice: Anatomical changes associated with enhanced fear memory. Brain Res 986(1-2):157-165.
12. Faraone SV, Biederman J. 1998. Neurobiology of attention-deficit hyperactivity disorder. Biol Psychiatry 44(10):951-958.
13. Faraone SV, Perlis RH, Doyle AE, Smoller JW, Goralnick JJ, Holmgren MA, Sklar P. 2005. Molecular genetics of attention-deficit/hyperactivity disorder. Biol Psychiatry 57(11):1313-1323.
14. Fuller RW, Wong DT. 1985. Effects of antidepressants on uptake and receptor systems in the brain. Prog Neuropsychopharmacol Biol Psychiatry 9(5-6):485-490.
15. Garenc C, Perusse L, Chagnon YC, Rankinen T, Gagnon J, Borecki IB, Leon AS, Skinner JS, Wilmore JH, Rao DC, et al. 2002. The alpha 2-adrenergic receptor gene and body fat content and distribution: The HERITAGE Family Study. Mol Med 8(2):88-94.
16. Gelernter J, Cubells JF, Kidd JR, Pakstis AJ, Kidd KK. 1999. Population studies of polymorphisms of the serotonin transporter protein gene. Am J Med Genet 88(1):61-66.
17. Himelstein J, Newcorn JH, Halperin JM. 2000. The neurobiology of attention-deficit hyperactivity disorder. Front Biosci 5:D461-D478.
18. Hoehe MR, Berrettini WH, Lentes KU. 1988. Dra I identifies a two allele DNA polymorphism in the human alpha 2-adrenergic receptor gene (ADRAR), using a 5.5 kb probe (p ADRAR). Nucleic Acids Res 16(18): 9070.
19. Karatekin C, Asarnow RF. 1998. Working memory in childhood-onset schizophrenia and attention-deficit/hyperactivity disorder. Psychiatry Res 80(2):165-176.
20. Lario S, Calls J, Cases A, Oriola J, Torras A, Rivera F. 1997. MspI identifies a biallelic polymorphism in the promoter region of the alpha 2A-adrenergic receptor gene. Clin Genet 51(2):129-130.
21. Michelson D, Faries D, Wernicke J, Kelsey D, Kendrick K, Sallee FR, Spencer T. 2001. Atomoxetine in the treatment of children and adolescents with attention-deficit/hyperactivity disorder: A randomized, placebo-controlled, dose-response study. Pediatrics 108(5):E83.
22. Michelson D, Adler L, Spencer T, Reimherr FW, West SA, Allen AJ, Kelsey D, Wernicke J, Dietrich A, Milton D. 2003. Atomoxetine in adults with ADHD: Two randomized, placebo-controlled studies. Biol Psychiatry 53(2):112-120.
23. Park L, Nigg JT, Waldman ID, Nummy KA, Huang-Pollock C, Rappley M, Friderici KH. 2005. Association and linkage of alpha-2A adrenergic receptor gene polymorphisms with childhood ADHD. Mol Psychiatry 10(6):572-580.
24. Pliszka SR, McCracken JT, Maas JW. 1996. Catecholamines in attention-deficit hyperactivity disorder: Current perspectives. J Am Acad Child Adolesc Psychiatry 35(3):264-272.
25. Roman T, Schmitz M, Polanczyk GV, Eizirik M, Rohde LA, Hutz MH. 2003. Is the alpha-2A adrenergic receptor gene (ADRA2A) associated with attention-deficit/hyperactivity disorder? Am J Med Genet B Neuropsychiatr Genet 120(1):116-120.
26. Spencer T, Biederman J, Wilens T, Prince J, Hatch M, Jones J, Harding M, Faraone SV, Seidman L. 1998. Effectiveness and tolerability of tomoxetine in adults with attention deficit hyperactivity disorder. Am J Psychiatry 155(5):693-695.
27. Xie X, Ott J. 1993. Testing linkage disequilibrium between a disease gene and marker loci. Am J Hum Genet 53:1107.
28. Xu C, Schachar R, Tannock R, Roberts W, Malone M, Kennedy JL, Barr CL. 2001. Linkage study of the alpha2A adrenergic receptor in attention-deficit hyperactivity disorder families. Am J Med Genet 105(2):159-162.
29. Zhao JH. 2002. 2LD- two-locus linkage disequilibrium (LD) calculator. Available from URL: http://www.iop.kcl.ac.uk/IoP/Departments/PsychMed/GEpiBSt/ software.shtml